ICLR
ICON Public Limited Company NASDAQ Listed May 15, 1998$146.00
+1.91%
vs $143.27
Mkt Cap $12.1B
52w Low $80.08
53.7% of range
52w High $202.92
50d MA $124.49
200d MA $149.71
P/E (TTM)
15.3x
EV/EBITDA
9.6x
P/B
1.3x
Debt/Equity
0.4x
ROE
8.5%
P/FCF
10.8x
RSI (14)
60.10
ATR (14)
$6.94
Beta
1.28
50d MA
$124.49
200d MA
$149.71
Avg Volume
1.1M
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
South County Business Park · Dublin, L2 18 · IE
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | AMC | 3.13 | 2.52 | -19.5% | 118.45 | -0.5% | +15.5% | -0.5% | +1.4% | -0.4% | +4.6% | — |
| Apr 29, 2026 | AMC | 3.19 | 3.28 | +2.8% | 116.17 | -0.9% | +1.9% | -4.6% | -0.8% | +8.4% | +2.3% | — |
| Oct 22, 2025 | AMC | 3.28 | 3.31 | +0.9% | 192.60 | -1.9% | -6.5% | -1.1% | +2.2% | -2.4% | -6.6% | — |
| Jul 23, 2025 | AMC | 3.19 | 3.26 | +2.2% | 167.89 | +20.3% | +16.2% | -4.1% | +1.4% | -2.3% | -2.0% | — |
| Apr 30, 2025 | AMC | 3.11 | 3.19 | +2.6% | 151.44 | -5.8% | -4.1% | -1.5% | +0.0% | -5.5% | +2.8% | — |
| Feb 19, 2025 | AMC | 3.41 | 3.43 | +0.6% | 191.32 | +1.9% | +5.5% | -0.2% | -1.1% | -0.8% | -0.7% | — |
| Oct 23, 2024 | AMC | 3.85 | 3.35 | -13.0% | 280.76 | -14.3% | -21.0% | -0.6% | +4.5% | +0.8% | -1.9% | — |
| Jul 24, 2024 | AMC | 3.68 | 3.75 | +1.9% | 331.77 | -6.6% | -5.6% | +3.3% | +1.8% | +0.4% | -0.6% | — |
| Apr 24, 2024 | AMC | 3.41 | 3.47 | +1.8% | 309.44 | +0.9% | -3.0% | +2.7% | -1.4% | -2.1% | +1.3% | — |
| Feb 21, 2024 | AMC | 3.44 | 3.46 | +0.6% | 284.70 | +5.9% | +10.1% | +0.3% | +1.4% | +1.2% | +0.3% | — |
| Oct 25, 2023 | AMC | 3.28 | 3.30 | +0.6% | 225.28 | +5.5% | +6.8% | -2.2% | +1.2% | +2.4% | +2.5% | — |
| Jul 26, 2023 | AMC | 3.08 | 3.11 | +1.0% | 253.10 | -3.9% | -4.5% | +4.3% | -0.3% | -0.9% | +0.9% | — |
| Apr 26, 2023 | AMC | 2.88 | 2.90 | +0.7% | 200.88 | +0.8% | -5.1% | +1.0% | +1.4% | -3.9% | -1.1% | — |
| Feb 22, 2023 | AMC | 3.06 | 3.13 | +2.3% | 221.71 | +2.8% | +0.6% | +0.2% | -0.2% | +1.1% | +0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 | RBC Capital Mkts | Reiterates | Sector Perform | $123 | $116.38 | $116.38 | +0.0% | -2.2% | -0.2% | +1.4% | +1.3% | +0.2% |
| Mar 26 | BMO Capital | Upgrade | Market Perform → Outperform | — | $99.99 | $101.63 | +1.6% | +3.1% | -1.0% | +3.0% | +5.3% | +0.7% |
| Mar 11 | Citigroup | Maintains | Neutral → Neutral | — | $106.62 | $107.12 | +0.5% | -1.2% | -7.5% | +0.9% | -0.7% | +3.0% |
| Mar 9 | Barclays | Maintains | Equal Weight → Equal Weight | — | $107.20 | $105.77 | -1.3% | +2.6% | -3.1% | -1.2% | -7.5% | +0.9% |
| Feb 23 | Jefferies | Upgrade | Hold → Buy | — | $99.70 | $100.68 | +1.0% | +5.0% | -0.5% | -3.0% | +5.1% | +1.9% |
| Feb 18 | TD Cowen | Upgrade | Hold → Buy | — | $88.62 | $89.26 | +0.7% | +8.9% | +2.0% | +1.3% | +5.0% | -0.5% |
| Jan 22 | TD Cowen | Maintains | Hold → Hold | — | $184.87 | $187.95 | +1.7% | +1.0% | -0.0% | +0.4% | +0.3% | -0.9% |
| Jan 8 | Truist | Downgrade | Buy → Hold | — | $202.92 | $179.07 | -11.8% | -7.2% | -3.6% | -0.7% | +1.7% | +0.8% |
| Dec 15 | Barclays | Maintains | Equal Weight → Equal Weight | — | $186.58 | $184.94 | -0.9% | -1.2% | -1.0% | -1.7% | -0.4% | -2.8% |
| Oct 24 | TD Cowen | Maintains | Hold → Hold | — | $180.00 | $179.22 | -0.4% | -1.1% | +2.2% | -2.4% | -6.6% | -0.4% |
| Oct 24 | Barclays | Maintains | Equal Weight → Equal Weight | — | $180.00 | $179.22 | -0.4% | -1.1% | +2.2% | -2.4% | -6.6% | -0.4% |
| Oct 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $192.31 | $190.26 | -1.1% | +0.3% | +0.5% | -1.8% | -2.0% | -0.1% |
| Sep 9 | Jefferies | Downgrade | Buy → Hold | — | $177.81 | $171.08 | -3.8% | -5.0% | -2.1% | +5.8% | -0.1% | -2.6% |
| Sep 3 | Rothschild & Co | Upgrade | Neutral → Buy | — | $177.84 | $182.05 | +2.4% | +1.2% | -2.0% | -0.8% | +1.7% | -5.0% |
| Sep 2 | Baird | Maintains | Outperform → Outperform | — | $177.94 | $176.65 | -0.7% | -0.1% | +1.2% | -2.0% | -0.8% | +1.7% |
| Aug 21 | Citigroup | Downgrade | Buy → Neutral | — | $180.25 | $177.01 | -1.8% | -2.5% | +0.1% | -2.3% | +0.0% | +1.3% |
| Jul 25 | Mizuho | Maintains | Outperform → Outperform | — | $195.01 | $193.41 | -0.8% | -4.1% | +1.4% | -2.3% | -2.0% | -6.8% |
| Jul 25 | Truist | Maintains | Buy → Buy | — | $195.01 | $193.41 | -0.8% | -4.1% | +1.4% | -2.3% | -2.0% | -6.8% |
| Jul 25 | Evercore ISI | Maintains | Outperform → Outperform | — | $195.01 | $193.41 | -0.8% | -4.1% | +1.4% | -2.3% | -2.0% | -6.8% |
| Jul 25 | UBS | Maintains | Buy → Buy | — | $195.01 | $193.41 | -0.8% | -4.1% | +1.4% | -2.3% | -2.0% | -6.8% |
| Jul 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $195.01 | $193.41 | -0.8% | -4.1% | +1.4% | -2.3% | -2.0% | -6.8% |
| Jul 24 | Baird | Upgrade | Neutral → Outperform | — | $167.89 | $202.04 | +20.3% | +16.2% | -4.1% | +1.4% | -2.3% | -2.0% |
| Jul 9 | Evercore ISI | Maintains | Outperform → Outperform | — | $151.58 | $152.85 | +0.8% | -0.7% | +1.0% | -1.0% | -0.7% | -2.6% |
| May 15 | Mizuho | Maintains | Outperform → Outperform | — | $132.23 | $131.41 | -0.6% | -1.2% | +0.7% | -0.7% | +1.0% | -4.1% |
| May 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $145.21 | $148.32 | +2.1% | -1.5% | +0.0% | -5.5% | +2.8% | -0.3% |
| May 2 | Baird | Maintains | Neutral → Neutral | — | $145.21 | $148.32 | +2.1% | -1.5% | +0.0% | -5.5% | +2.8% | -0.3% |
| May 2 | Goldman Sachs | Maintains | Neutral → Neutral | — | $145.21 | $148.32 | +2.1% | -1.5% | +0.0% | -5.5% | +2.8% | -0.3% |
| Apr 29 | JP Morgan | Downgrade | Overweight → Neutral | — | $145.00 | $142.89 | -1.5% | +3.0% | +1.4% | -4.1% | -1.5% | +0.0% |
| Apr 14 | TD Cowen | Downgrade | Buy → Hold | — | $144.04 | $144.54 | +0.3% | +1.9% | -1.1% | -1.1% | -2.9% | -1.5% |
| Apr 10 | Barclays | Downgrade | Overweight → Equal Weight | — | $155.49 | $148.51 | -4.5% | -8.3% | +1.0% | +1.9% | -1.1% | -1.1% |
| Apr 10 | Truist | Maintains | Buy → Buy | — | $155.49 | $148.51 | -4.5% | -8.3% | +1.0% | +1.9% | -1.1% | -1.1% |
| Apr 9 | Mizuho | Maintains | Outperform → Outperform | — | $142.50 | $141.08 | -1.0% | +9.1% | -8.3% | +1.0% | +1.9% | -1.1% |
| Apr 7 | Citigroup | Maintains | Buy → Buy | — | $153.72 | $149.22 | -2.9% | -1.9% | -5.5% | +9.1% | -8.3% | +1.0% |
| Mar 21 | Goldman Sachs | Downgrade | Buy → Neutral | — | $183.96 | $177.92 | -3.3% | +0.5% | -0.2% | -2.9% | -0.1% | +0.7% |
| Mar 4 | Baird | Maintains | Neutral → Neutral | — | $184.81 | $184.71 | -0.1% | -0.6% | +1.6% | -0.7% | +0.7% | -2.1% |
| Feb 21 | Barclays | Maintains | Overweight → Overweight | — | $201.84 | $204.68 | +1.4% | -0.2% | -1.1% | -0.8% | -0.7% | -3.3% |
| Feb 13 | Truist | Maintains | Buy → Buy | — | $186.53 | $186.25 | -0.2% | -2.1% | +2.0% | +1.3% | +1.4% | +5.5% |
| Feb 3 | JP Morgan | Maintains | Overweight → Overweight | — | $199.08 | $194.19 | -2.5% | -1.8% | -1.1% | +1.6% | -0.2% | -1.3% |
| Jan 15 | RBC Capital | Maintains | Outperform → Outperform | — | $200.24 | $204.19 | +2.0% | -0.4% | +1.5% | -2.2% | +3.5% | -1.0% |
| Jan 14 | William Blair | Maintains | Outperform → Outperform | — | $217.99 | $199.39 | -8.5% | -8.1% | -0.4% | +1.5% | -2.2% | +3.5% |
| Jan 6 | Citigroup | Maintains | Buy → Buy | — | $213.28 | $214.11 | +0.4% | +1.0% | +3.3% | -1.5% | -0.5% | -0.1% |
| Dec 18 | Truist | Maintains | Buy → Buy | — | $203.26 | $203.93 | +0.3% | +0.6% | +0.1% | +1.4% | +1.2% | +1.5% |
| Nov 20 | Baird | Maintains | Neutral → Neutral | — | $195.60 | $196.67 | +0.5% | +4.1% | +4.5% | +0.7% | +1.2% | -2.1% |
| Nov 19 | Leerink Partners | Maintains | Outperform → Outperform | — | $187.22 | $186.79 | -0.2% | +4.5% | +4.1% | +4.5% | +0.7% | +1.2% |
| Oct 28 | Truist | Maintains | Buy → Buy | — | $220.47 | $221.26 | +0.4% | +4.5% | +0.8% | -1.9% | -2.5% | -0.8% |
| Oct 25 | JP Morgan | Maintains | Overweight → Overweight | — | $221.73 | $224.79 | +1.4% | -0.6% | +4.5% | +0.8% | -1.9% | -2.5% |
| Oct 25 | Leerink Partners | Maintains | Outperform → Outperform | — | $221.73 | $224.79 | +1.4% | -0.6% | +4.5% | +0.8% | -1.9% | -2.5% |
| Oct 25 | TD Cowen | Maintains | Buy → Buy | — | $221.73 | $224.79 | +1.4% | -0.6% | +4.5% | +0.8% | -1.9% | -2.5% |
| Oct 25 | Goldman Sachs | Maintains | Buy → Buy | — | $221.73 | $224.79 | +1.4% | -0.6% | +4.5% | +0.8% | -1.9% | -2.5% |
| Oct 25 | Baird | Maintains | Neutral → Neutral | — | $221.73 | $224.79 | +1.4% | -0.6% | +4.5% | +0.8% | -1.9% | -2.5% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Artisan Partners Limited Partnership | 8,278,945 | $916M | Added | Mar 2026 |
| 2 | Principal Financial Group Inc | 3,001,535 | $547M | Reduced | Dec 2025 |
| 3 | Fmr Llc | 4,174,006 | $462M | Added | Mar 2026 |
| 4 | Invesco Ltd. | 3,878,869 | $429M | Added | Mar 2026 |
| 5 | Greenhaven Associates Inc | 2,002,411 | $222M | Added | Mar 2026 |
| 6 | Ruane, Cunniff & Goldfarb L.p. | 1,634,611 | $181M | Reduced | Mar 2026 |
| 7 | Morgan Stanley | 947,278 | $173M | Reduced | Dec 2025 |
| 8 | D.e. Shaw & Co | 1,198,555 | $133M | Added | Mar 2026 |
| 9 | 1832 Asset Management L.p. | 1,193,240 | $132M | Reduced | Mar 2026 |
| 10 | Jennison Associates Llc | 677,981 | $124M | New | Dec 2025 |
| 11 | Capital World Investors | 1,104,831 | $122M | Reduced | Mar 2026 |
| 12 | Equity Investment Corp | 1,096,395 | $121M | Added | Mar 2026 |
| 13 | First Pacific Advisors, Lp | 991,075 | $110M | Added | Mar 2026 |
| 14 | Lyrical Asset Management Lp | 938,204 | $104M | Reduced | Mar 2026 |
| 15 | Boston Partners | 835,139 | $92M | Reduced | Mar 2026 |
| 16 | Franklin Resources Inc | 816,085 | $86M | Reduced | Mar 2026 |
| 17 | Sei Investments Co | 757,489 | $84M | Reduced | Mar 2026 |
| 18 | Voya Investment Management Llc | 438,319 | $80M | Added | Dec 2025 |
| 19 | Ubs Group Ag | 612,265 | $68M | Added | Mar 2026 |
| 20 | Lakewood Capital Management, Lp | 332,500 | $61M | Added | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$12.12B
Enterprise Value
$14.98B
P/E (TTM)
15.32x
Forward P/E
12.14x
PEG Ratio
0.76x
P/B
1.26x
P/S
1.46x
P/FCF
10.84x
EV/EBITDA
9.58x
Shares Out
83.0M
Financials (TTM)
Revenue
$8.28B
Net Income
$791.5M
EBITDA
$1.56B
Free Cash Flow
$1.12B
Op Cash Flow
$1.29B
EPS Basic
$9.60
EPS Diluted
$9.53
EPS Forward
$12.03
Gross Margin
29.4%
Op Margin
13.3%
Net Margin
9.6%
Balance Sheet
Total Assets
$16.88B
Total Liab.
$7.35B
Total Equity
$9.52B
Cash
$538.8M
LT Debt
$3.40B
Book Value/Sh
$115.45
Debt/Equity
0.38x
Current Ratio
1.26
Quick Ratio
1.26
Returns & Growth
ROE
8.5%
ROA
4.8%
ROIC
7.1%
Rev Growth YoY
+2.0%
EPS Growth YoY
+28.7%
Price Returns
2W
+16.2%
1M
+15.0%
3M
+25.8%
6M
-26.4%
12M
+4.4%
Technicals
52W High
$202.92
52W Low
$80.08
50d MA
$124.49
200d MA
$149.71
RSI (14)
60.10
ATR (14)
$6.94
Beta
1.28
Avg Volume
1.1M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$149.63
High
$222.00
Low
$100.00
Median
$127.00
Data updated apr 25, 2026 2:52pm
· Source: financialmodelingprep.com